These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34368076)

  • 1. Identification of Potential Binding Sites of Sialic Acids on the RBD Domain of SARS-CoV-2 Spike Protein.
    Li B; Wang L; Ge H; Zhang X; Ren P; Guo Y; Chen W; Li J; Zhu W; Chen W; Zhu L; Bai F
    Front Chem; 2021; 9():659764. PubMed ID: 34368076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of cell surface sialic acids for SARS-CoV-2 infection.
    Sun XL
    Glycobiology; 2021 Nov; 31(10):1245-1253. PubMed ID: 33909065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening of inhibitors against SARS-CoV-2 spike protein and their capability to block the viral entry mechanism: A viroinformatics study.
    Farouk AE; Baig MH; Khan MI; Park T; Alotaibi SS; Dong JJ
    Saudi J Biol Sci; 2021 Jun; 28(6):3262-3269. PubMed ID: 33654454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Species-Specific Colocalization of Middle East Respiratory Syndrome Coronavirus Attachment and Entry Receptors.
    Widagdo W; Okba NMA; Li W; de Jong A; de Swart RL; Begeman L; van den Brand JMA; Bosch BJ; Haagmans BL
    J Virol; 2019 Aug; 93(16):. PubMed ID: 31167913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The SARS-CoV-2 spike N-terminal domain engages 9-
    Tomris I; Unione L; Nguyen L; Zaree P; Bouwman KM; Liu L; Li Z; Fok JA; Ríos Carrasco M; van der Woude R; Kimpel ALM; Linthorst MW; Verpalen ECJM; Caniels TG; Sanders RW; Heesters BA; Pieters RJ; Jiménez-Barbero J; Klassen JS; Boons GJ; de Vries RP
    bioRxiv; 2022 Oct; ():. PubMed ID: 36263070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants.
    Tai W; Wang Y; Fett CA; Zhao G; Li F; Perlman S; Jiang S; Zhou Y; Du L
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the SARS-CoV-2 Spike Protein Receptor Binding Domain Interact Effectively with the DPP4 (CD26) Receptor? A Molecular Docking Study.
    Cameron K; Rozano L; Falasca M; Mancera RL
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of sialic acid-binding function for the Middle East respiratory syndrome coronavirus spike glycoprotein.
    Li W; Hulswit RJG; Widjaja I; Raj VS; McBride R; Peng W; Widagdo W; Tortorici MA; van Dieren B; Lang Y; van Lent JWM; Paulson JC; de Haan CAM; de Groot RJ; van Kuppeveld FJM; Haagmans BL; Bosch BJ
    Proc Natl Acad Sci U S A; 2017 Oct; 114(40):E8508-E8517. PubMed ID: 28923942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the Spike Protein of Middle East Respiratory Syndrome Coronavirus Transmitted in Korea Increase Resistance to Antibody-Mediated Neutralization.
    Kleine-Weber H; Elzayat MT; Wang L; Graham BS; Müller MA; Drosten C; Pöhlmann S; Hoffmann M
    J Virol; 2019 Jan; 93(2):. PubMed ID: 30404801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 and MERS-CoV Spike Protein Binding Studies Support Stable Mimic of Bound 9-
    Oh L; Varki A; Chen X; Wang LP
    Molecules; 2022 Aug; 27(16):. PubMed ID: 36014560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the Receptor-Binding Domain of the Spike Glycoprotein of Human Betacoronavirus HKU1.
    Qian Z; Ou X; Góes LG; Osborne C; Castano A; Holmes KV; Dominguez SR
    J Virol; 2015 Sep; 89(17):8816-27. PubMed ID: 26085157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational design and modeling of nanobodies toward SARS-CoV-2 receptor binding domain.
    Yang J; Zhang Z; Yang F; Zhang H; Wu H; Zhu F; Xue W
    Chem Biol Drug Des; 2021 Jul; 98(1):1-18. PubMed ID: 33894099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 Spike N-Terminal Domain Engages 9-
    Tomris I; Unione L; Nguyen L; Zaree P; Bouwman KM; Liu L; Li Z; Fok JA; Ríos Carrasco M; van der Woude R; Kimpel ALM; Linthorst MW; Kilavuzoglu SE; Verpalen ECJM; Caniels TG; Sanders RW; Heesters BA; Pieters RJ; Jiménez-Barbero J; Klassen JS; Boons GJ; de Vries RP
    ACS Chem Biol; 2023 May; 18(5):1180-1191. PubMed ID: 37104622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis of severe acute respiratory syndrome coronavirus 2 infection.
    Ge J; Zhang S; Zhang L; Wang X
    Curr Opin HIV AIDS; 2021 Jan; 16(1):74-81. PubMed ID: 33186231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomechanical Characterization of SARS-CoV-2 Spike RBD and Human ACE2 Protein-Protein Interaction.
    Cao W; Dong C; Kim S; Hou D; Tai W; Du L; Im W; Zhang XF
    bioRxiv; 2020 Jul; ():. PubMed ID: 32766576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular insights into the binding variance of the SARS-CoV-2 spike with human, cat and dog ACE2 proteins.
    Zang Y; Li X; Zhao Y; Wang H; Hao D; Zhang L; Yang Z; Yuan X; Zhang S
    Phys Chem Chem Phys; 2021 Jun; 23(24):13752-13759. PubMed ID: 34132301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 Pathogen Viral Evolution Leading to Increased Infectivity.
    Parag S; Carnevale K
    Cureus; 2022 Jul; 14(7):e26660. PubMed ID: 35949765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus-Host Interaction.
    Kim CH
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32604730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human neutralizing antibodies elicited by SARS-CoV-2 infection.
    Ju B; Zhang Q; Ge J; Wang R; Sun J; Ge X; Yu J; Shan S; Zhou B; Song S; Tang X; Yu J; Lan J; Yuan J; Wang H; Zhao J; Zhang S; Wang Y; Shi X; Liu L; Zhao J; Wang X; Zhang Z; Zhang L
    Nature; 2020 Aug; 584(7819):115-119. PubMed ID: 32454513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Engineered Receptor-Binding Domain Improves the Immunogenicity of Multivalent SARS-CoV-2 Vaccines.
    Guo Y; He W; Mou H; Zhang L; Chang J; Peng S; Ojha A; Tavora R; Parcells MS; Luo G; Li W; Zhong G; Choe H; Farzan M; Quinlan BD
    mBio; 2021 May; 12(3):. PubMed ID: 33975938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.